A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Pharmacodynamics, Pharmacokinetics, and Tolerability of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation

Trial Profile

A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Pharmacodynamics, Pharmacokinetics, and Tolerability of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2014

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation
  • Focus Registrational; Therapeutic Use
  • Sponsors Sucampo Pharmaceuticals
  • Most Recent Events

    • 24 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2014 Results have been reported in a Sucampo Pharmaceuticals media release.
    • 14 Mar 2014 Based on results obtained, which failed to demonstrate a statistically significant between-group difference in spontaneous bowel movement, Sucampo has indicated that an NDA will no longer be filed in the second half of 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top